David E. Nichols
David Earl Nichols | |
---|---|
Medicinal Chemistry, Pharmacology | |
Institutions | Purdue University, Indiana University School of Medicine |
David Earl Nichols (born December 23, 1944,
He is the founding president of the
Education
- BS - 1969 - University of Cincinnati[4]
- PhD - 1973 - University of Iowa
- Postdoc Work - 1973-74 - University of Iowa
Research areas
Nichols is still carrying out academic research on the chemistry of psychedelics. He has published approximately 250 scientific reports and book chapters, all describing the relationship between the structure of a molecule and its biological effects (often referred to as a
Other notable research that he helped carry out includes extensive studies of the structure-activity relationships and mechanisms of action of
More recently, Nichols has become one of the world leaders in research on dopamine, and his team has developed several notable dopamine receptor ligands, including the selective D1 full agonist compounds dihydrexidine and dinapsoline which have been researched for the treatment of Parkinson's disease, as well as a number of other subtype-selective dopamine agonists derived from dinoxyline. He co-founded DarPharma, Inc. to commercialize his dopamine compounds; several of his team's compounds are now being studied in clinical trials for the treatment of Parkinson's disease and the cognitive and memory deficits of schizophrenia.
Impact on the designer drug market
Designer drug producers who scan scientific literature for information on compounds with potential grey market value have described Nichols' publications as an "especially valuable" road map to making new designer drugs.[7] Several deaths have been attributed to compounds that have been discovered in Nichols' lab, which he finds quite upsetting, "I was stunned by this revelation, and it left me with a hollow and depressed feeling for some time."[8]
See also
References
- ^ "The Heffter Review of Psychedelic Research, Volume 1, 1998 - 5. The Medicinal Chemistry of Phenethylamine Psychedelics by David E. Nichols, Ph.D." (PDF). Archived from the original (PDF) on 2008-07-04.
- ^ "Home". serotoninclub.org.
- ^ "David Nichols".Archived 2022-09-06 at the Wayback Machine
- ^ "David E. Nichols, PhD, Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology". Archived from the original on 2010-04-21. Retrieved 2010-04-09.
- ISBN 9781461441205.
- Reason
- ^ Whalen, Jeanne (Oct 30, 2010). "In Quest for 'Legal High,' Chemists Outfox Law". The Wall Street Journal. Retrieved 10 September 2013.
- PMID 21209630.
Further reading
- The Medicinal Chemistry of Phenethylamine Psychedelics Archived 2010-06-13 at the Wayback Machine
- LSD and Its Lysergamide Cousins Archived 2010-06-13 at the Wayback Machine
External links
- Purdue University - Nichols
- Erowid Character Vaults: David E. Nichols
- Heffter Research Institute
- LSD Neuroscience Nichols's lecture in Psychedelic Science 2013 conference.
- Advances In Understanding How Psychedelics Work In The Brain Nichols's lecture in the Psychedelic Science in the 21st Century conference in 2010.
- David E. Nichols interviewed by Jan Irvin (2010)